What We Do

Download Resources
Product Information

Regional Information
Australia | Canada | Europe
Latin America | United States

Research & Development
Dermatology & Neurology Pipeline
More

News & Stock

05/03/2012
Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
NYSE: VRX
Current Price: 47.03
Change: -1.25
May 18 | 20 minute delay
More

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics in the United States, Canada, Latin America, Eastern and Central Europe, Australia, South East Asia and South Africa.